⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18902512 | 1.00 | LMNA (0.45) | — | |
| SCHEMBL2515557 | 1.00 | LMNA (0.45) | — | |
| SCHEMBL7487393 | 1.00 | LMNA (0.45) | — | |
| SCHEMBL4602333 | 1.00 | — | — | |
| SCHEMBL283183 | 0.97 | — | — | |
| SCHEMBL101773 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL18130992 | 0.84 | — | — | |
| SCHEMBL7155535 | 0.83 | TRPA1 (0.50) | — | |
| SCHEMBL7156742 | 0.83 | TRPA1 (0.50) | — | |
| SCHEMBL7155007 | 0.83 | TRPA1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3037424-B1 | NOVEL QUINOLINE-SUBSTITUTED COMPOUND | TAIHO PHARMACEUTICAL CO LTD (JP) | 2017-11-08 | — | — | EP | disclosed |
| US-20150210701-A1 | TREATMENT OF HELICOBACTER PYLORI INFECTIONS | ALBERTEINSTIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2015-07-30 | — | — | US | disclosed |
| WO-2014025842-A1 | TREATMENT OF HELICOBACTER PYLORI INFECTIONS | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2014-02-13 | — | — | WO | disclosed |
| US-20110028746-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2011-02-03 | — | — | US | disclosed |
| EP-2268397-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF , ALPHA, BETA -UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009118341-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF α,β-UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2009-10-01 | — | — | WO | disclosed |
| EP-1460071-B1 | N-HETEROARYLNICOTINAMIDE DERIVATIVES | MITSUI CHEMICALS AGRO INC (JP) | 2009-09-16 | — | — | EP | disclosed |
| US-7399775-B2 | β-amyloid protein production/secretion inhibitor | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20080039816-A1 | Carbohydrate-Encapsulated Quantum Dots for Bilogical Imaging | The Government of the United States of America as represented by the Secretary, Department of (US) | 2008-02-14 | — | — | US | disclosed |
| US-20070293495-A1 | BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1466898-A1 | BETA-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-10-13 | — | — | EP | disclosed |
| EP-1460071-A1 | N-HETEROARYLNICOTINAMIDE DERIVATIVES | Sankyo Agro Company, Limited (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-6525000-B1 | N-aminoureas are reacted with formaldehyde to give methyleneimino ureas, cyclizing these to give tetrahydro-4H-1,3,4-oxa(or thia)diazines, and cyclizing the fused triazoles using phosgene; herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-25 | — | — | US | disclosed |
| EP-1095045-B1 | METHOD FOR PRODUCING ANELLATED TRIAZOLES AND NEW ANELLATED TRIAZOLES AND THEIR USE | BASF AG (DE) | 2003-01-15 | — | — | EP | disclosed |
| EP-0835248-B1 | 1-AMINO-3-BENZYLURACILS | BASF AG (DE) | 2001-02-21 | — | — | EP | disclosed |
| EP-0835248-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-15 | — | — | EP | disclosed |
| US-5691319-A | ANTICARCINOGENIC AGENTS | SANKYO COMPANY, LIMITED (JP) | 1997-11-25 | — | — | US | disclosed |
| WO-1997001543-A1 | 1-AMINO-3-BENZYLURACILS | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-16 | — | — | WO | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |